For some people, HIV feels like something that happens to “other people.” It’s a distant issue — something for a different ...

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis ...

Heterosexual people with HIV-positive partners: PrEP provides protection for HIV-negative partners in serodiscordant relationships. People who inject drugs : Sharing needles increases the risk of ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Even with the HIV prevention waters now dominated by Gilead Science’s Yeztugo (lenacapavir), Merck & Co. is not afraid to swim deeper in. | Even with the HIV prevention waters now dominated by Gilead ...

PrEP (pre-exposure prophylaxis) is medicine that helps protect you from the human immunodeficiency virus (HIV), which causes AIDS. Learn about how it works, how well it works, who’s most likely ...

PrEP is an antiretroviral medication proven to reduce HIV infections from sex by as much as 99%. It is sold as a daily pill under brand names Truvada and Descovy, as well as generic versions.

But Lutz said, when people can access it, PrEP is a game-changer for preventing HIV transmission. Before PrEP, condoms and other types of barriers were the main method of prevention. “Condoms ...